Abstract
The 2015 American Thyroid Association guidelines reinforce the central role of thyroid fine‐needle aspiration in the management of patients with concerning thyroid nodules. Of particular note to the cytology community, the guidelines endorse: 1) nodule selection for fine‐needle aspiration based on size and ultrasonographic risk stratification; 2) adoption of The Bethesda System for Reporting Thyroid Cytopathology; and 3) a role for molecular testing in the management of thyroid nodules with indeterminate cytology results.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
